Cover Image

Guidance for industry efficacy studies to support marketing of fibrin sealant products manufactured for commercial use.

Other Authors:	Center for Biologics Evaluation and Research (U.S.)
Format:	Electronic
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [1999]
Physical Description:	i, 3 pages : digital, PDF file.
Subjects:	Fibrin. Sealing compounds -- Marketing -- Government policy -- United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113530

Similar Items

Guidance for industry for the submission of chemistry, manufacturing and controls and establishment description information for human blood and blood components intended for transfusion or for further manufacture and for the completion of the form FDA 356h "Application to market a new drug, biologic or an antibiotic drug for human use"
Published: (1999)

Points to consider in the manufacture and testing of monoclonal antibody products for human use
Published: (1997)

Guidance for industry year 2000 date change for computer systems and software applications used in the manufacture of blood products
Published: (1998)

Career development programs guide
Published: (1987)

The NIH Training Center
Published: (1987)

Guidance for industry patient-reported outcome measures, use in medical product development to support labeling claims
Published: (2006)

Guidance for industry IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer
Published: (2004)

Guidance for industry source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans
Published: (2003)

Employment opportunities in aviation occupations
by: Wood, Helen, 1907-2002,
Published: (1945)

The Health field needs you
Published: (1986)

Guidance for industry M4E, the CTD, efficacy
Published: (2001)

NIOSH recommendations for occupational safety and health compendium of policy documents and statements
by: National Institute for Occupational Safety and Health.
Published: (1992)

Guidance PET drug products, current good manufacturing practice (CGMP)
Published: (2005)

Guidance for industry changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture
Published: (2001)

An invitation to involvement : engineering career opportunities in the U.S. Public Health Service
by: United States. Public Health Service.
Published: (1991)

Information sheet guidance for institutional review boards and clinical investigators ("off-label" and investigational use of marketed drugs, biologics, and medical devices)
Published: (1998)

Guide to inspections of cosmetic product manufacturers
Published: (1995)

Redesigning a Product
Published: (2010)

ASSIST shaping the future of tobacco prevention and control
Published: (2005)

Guidance for industry on the content and format of chemistry, manufacturing and controls information and establishment description information for an allergenic extract or allergen patch test
Published: (1999)

Guidance for industry comparability protocols, protein drug products and biological products; chemistry, manufacturing, and controls information
Published: (2003)

Draft guidance for industry and FDA staff technical considerations for pen, jet, and related injectors intended for use with drugs and biological products
Published: (2009)

Guidance for industry for platelet testing and evaluation of platelet substitute products
Published: (1999)

Guidance for industry providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications
Published: (2008)

Guidance for industry public health issues posed by the use of nonhuman primate xenografts in humans
Published: (1999)

Fact sheet I, FDA's new interim final rule prohibiting use of certain cattle materials that may carry the risk of bovine spongiform encephalopathy in human foods and cosmetics, and II, FDA's proposed rule on recordkeeping requirements for human food and cosmetics manufactured from, processed with, or otherwise containing material from cattle
Published: (2004)

Guidance for industry and FDA staff devices used to process human cells, tissues, and cellular and tissue-based products (HCT/Ps)
Published: (2007)

The United States food safety system
Published: (2000)

Food safety current and emerging issues influencing public health and trade : U.S. food safety outreach meeting highlights, European Union, Brussels, Belgium; Warsaw, Poland; Prague, Czech Republic; Budapest, Hungary
Published: (2002)

Guidance for industry reports on the status of postmarketing study commitments : implementation of section 130 of the Food and Drug Administration Modernization Act of 1997
Published: (2006)

Information sheet guidance for institutional review boards and clinical investigators (use of investigational products when subjects enter a second institution)
Published: (1998)

Guide to inspections of dairy product manufacturers
Published: (1995)

Guidance for industry precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts
Published: (1999)

Guidance for industry use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)
Published: (2009)

Guidance for industry in the manufacture and clinical evaluation of in vitro tests to detect nucleic acid sequences of human immunodeficiency viruses types 1 and 2
Published: (1999)

Guidance for industry computerized systems used in clinical trials
Published: (1999)

Guide to inspections of manufacturers of miscellaneous food products
Published: (1995)

What you need to know about registration of food facilities
Published: (2003)

CDC Disease Detective Camp
Published: (2010)

Guidance for industry, FDA staff, and FDA-accredited third parties. Manufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)
Published: (2009)